Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27−0.09 (-25.05%)
Close on Nov 17, 2026Market cap $2.88MP/E –Yield –
Gelteq total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Gelteq's total debt was A$5.11M at Dec 31, 2025. For fiscal 2025 it was A$8.42M, up 50.3% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | A$8.42M | +50.3% |
| FY2024 | Jun 30, 2024 | A$5.60M | +126.2% |
| FY2023 | Jun 30, 2023 | A$2.48M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | A$5.11M | +106.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$8.42M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | A$3.90M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$5.60M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$2.48M | – |
See a number that looks wrong?